Top Markets
#1 Nesa Nesa +820.50%
#2 Cortex Cortex +68.91%
#3 Kinesis Silver Kinesis Silver +57.40%
#4 Merlin's Seal BTC Merlin's Seal BTC +45.66%
#5 QuantixAI QuantixAI +24.05%
#6 EXOD EXOD +22.78%
#7 Cash Cat Cash Cat +20.46%
#8 OpenEden OpenEden +19.61%
#9 Palladium Network Palladium Network +18.94%
#10 Instadapp Instadapp +16.15%
Coin of the day
Nesa Nesa
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Jilin Province Huinan Changlong Bio-pharmacy Company Limited

8049
Classifica tra le azioni #19267
Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the... Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive product portfolio includes a wide range of dosage forms such as tablets, capsules, and pills, as well as specialized items like Chinese medicine pretreatment and extraction products. They also provide various injectable solutions, including powders for injection, lyophilized powders for injection, and small volume liquid injections, along with active pharmaceutical ingredients (APIs) and granules. These products are primarily sold under the "Changlong" and "Qing Tong" brand names. Established in 1989, and headquartered in Kowloon, Hong Kong, the company was previously known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.
Prezzo delle azioni
$0.29998701
Capitalizzazione di mercato
$168.04M
Variazione (1 giorno)
0.21%
Variazione (1 anno)
10.81%
Paese
CN
Scambia Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049)

Categoria

Healthcare
Ricavi di Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Jilin Province Huinan Changlong Bio-pharmacy Company Limited, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Jilin Province Huinan Changlong Bio-pharmacy Company Limited da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN